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NomeNclature
 WBC White blood cell
 SSB Single strand break
 DSB Double strand break
 Ser  Serine
 CBC Complete blood count
 PBS Phosphate buffer saline
 RBC Red blood cells
 BSA Bovine serum albumin
 FITC Fluorescin isothiocyanate
 SD  Standard deviation
 MFI Mean fluorescence intensity
 Del  Terminal deletion 
 DM Double minute
 RT  Robertsonian translocation
 EEA End to end association
1.  INtroDuctIoN 
Cancer is a symptom in which abnormal cells divide in an 
uncontrolled manner and destroy body tissue1. Radiotherapy 
has been commonly used in clinics for treatment of cancer2. 
The total dose estimation for patient plays an important role 
in maximizing the effectiveness of treatment which is decided 
by various factors like type of tumour, size, and proliferation3. 
The main side effect of the radiotherapy is damage to the 
surrounding healthy cells due to direct exposure or by the 
bystander effect4,5. The main focus of the treatment is to kill 
maximum number of cancer cells with minimum damage to 
the normal cells6,7. To achieve this objective, splitting dose 
technique is used in which clinically relevant radiation dose is 
delivered at multiple times to the patients over a period of time 
to provide time gap which allows the healthy cell to repair the 
radiation mediated damage8.
There are various reports conveying the measurement of 
DNA damage biomarkers for evaluation of the effectiveness of 
cancer therapy9,10. These biomolecules also help in measuring 
the damage level in normal healthy cells11. Radiation-induced 
DNA damage has various outcome like single strand breaks 
(SSBs), double strand breaks (DSBs), base modifications, 
etc12-14. DSBs are regarded as lethal lesions due to difficulty 
in their repair15. Recently, γH2AX has been used as biomarker 
for the measurement of DNA double strand breaks12,16. This 
protein belongs to H2A family and gets phosphorylated at 
ser 139 position on generation of double strand break17,18. 
Published literature cites the availability of γH2AX in cells 
with-in minutes of damage which can stay upto hours and 
months depending upon the type of system and radiation 
exposure scenarios19. The phosphorylation event of H2AX is 
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mediated by kinases of the PI3 family which includes ATM, 
ATR, and DNA-PKcs20. This biomarker protein has reportedly 
been used to monitor the effectiveness of radiation doses to 
the human subjects in clinics21,22. The level of γH2AX has 
been linked to absorbed dose and serves as a predictor of 
radiosensitivity23.
After DNA damage, the body repair mechanism gets 
activated and repairs the broken end of the DNA24. The broken 
ends may rejoin in different patterns from their original 
arrangement and cause abnormalities25. These abnormalities 
referred as chromosomal aberrations which include fragments, 
rings, dicentrics, gaps, terminal deletion (del), centromeric 
attenuation, end to end association (EEA) and robertsonian 
translocations (RT)26,27. Assessment of chromosomal aberration 
can give an idea about the severity of damages and can also give 
a clear picture about the functioning of the repair mechanism.
During radiotherapy treatment, blood haematology plays 
an important role in indicating the overall body status of the 
patient28. Several reports show severe fall in blood cell count 
after radiotherapy treatment following which the patient may 
need blood transfusion depending on the CBC status29. 
Tumour cells are killed by each consecutive dose 
of radiation during radiotherapy treatment7,30. However, 
information is not available about response of normal cells after 
repeated exposure. The radiosensitivity of normal and tumour 
cells differ significantly. The current investigation measures the 
damage level in healthy cells exposed to the repeated exposure 
under radiotherapy setting using latest γH2AX technique and 
conventional chromosomal and blood haematology assays.
2. materIalS aND metHoDS
2.1 chemicals
Sodium chloride (S3014), potassium chloride (P9541), 
sodium phosphate dibasic (S3264), potassium phosphate 
monobasic (P9791), potassium bicarbonate (12602), 
ammonium chloride (A9434), ethylenediaminetetracetic acid 
di-sodium salt  (EDTA) (E6635), paraformaldehyde (158127), 
Triton X-100 (T8787), bovine serum albumin (S5482), 
colchicines (SC9754) and glycerine ( 44892) were obtained 
from Sigma-Aldrich. Anti-phospho-histone γH2AX Ser 139 
monoclonal antibody (05-636) and goat anti-mouse IgG (H+ 
L) fluorescein-conjugated antibody (02-506) were obtained 
from Merck-Millipore. Methanol (Himedia, MB113), acetic 
acid (Merck, 100056), Giemsa acid (Fisher scientific, G146) 
were purchased from specific manufacturer for this work. 
1L 1X PBS (8 g of sodium chloride, 0.2 g of potassium 
chloride, 1.44 g of sodium phosphate dibasic, 0.25 g of 
potassium phosphate monobasic to 1 L at pH 7.4), 1L 1X RBC 
lysis buffer (1 g of potassium bicarbonate, 8 g of ammonium 
chloride and 0.03 g of di-sodium EDTA), the paraformaldehyde 
(3%), 50 mM ammonium chloride, 0.5% Triton X-100/PBS, 
10% BSA/PBS and 0.1% Triton X-100/PBS solutions were 
prepared in the laboratory. For chromosomal aberration assay 
0.075 M of potassium chloride solution, fixative solution 
(methanol and acetic acid solution in 3:1 ratio) and 5% Giemsa 
solution (3.8 g of Giemsa in 250 ml of methanol and 250 ml of 
glycerine) were prepared in the laboratory. 
2.2 animals
Strain ‘A’ male mice (10-12 weeks old and 25 g - 30 g 
weight) were used for the experiments. Mice were housed with 
6 animals per cage with standard pellet diet and water. In the 
animal house, 12 h dark/ light cycle was maintained with the 
temperature of 25 °C - 30 °C. 
2.3 ethics Statement 
All the experiments  performed on mice were approved 
by the committee on the Ethics of Animal Experiments of the 
Institute of Nuclear Medicine and Allied Sciences (INMAS) 
and the Defence Research and Development Organisation 
(DRDO) of Delhi, India (Institute Animal Ethics Committee 
number: INM/IAEC/2016/21 valid until 23/02/2017). The 
experiments were conducted according to the general national 
guidelines that were set forth by the Committee for the Purpose 
of Control and Supervision of Experiments on Animals 
(CPCSEA) of the Government of India. 
2.4 treatment Groups and time Points
Mice were divided into six groups as follows:
(i) Untreated: Non-irradiated mice. 
(ii) 1st fraction: Localised radiation of 2 Gy to right leg region 
of the mice and the radiation was given in a single go.
(iii) 2nd fraction: Localised radiation of 4 Gy to right leg region 
of the mice and the radiation given as 2 Gy per day for 2 
consecutive days.
(iv) 3rd fraction: Localised radiation of 6 Gy to right leg region 
of the mice and the radiation given as 2 Gy per day for 3 
consecutive days.
(v) 4th fraction: Localised radiation of 8 Gy to right leg region 
of the mice and the radiation given as 2 Gy per day for 4 
consecutive days.
(vi) 5th fraction: Localised radiation of 10 Gy to right leg 
region of the mice and the radiation given as 2 Gy per day 
for 5 consecutive days.
All the three studies performed in the current study, i.e. 
blood haematology, γH2AX measurement and chromosomal 
aberration study, were performed in all the treatment groups as 
mentioned above. However, blood haematology and γH2AX 
measurement studies were performed in a set of animals with 
6 animals/ group at 1 h and the chromosomal aberration study 
was performed in a separate set of animals which also contains 
6 animals/ group on 24 h.
2.5 radiation
Mice were kept in a restrainer and right leg was exposed 
to 2 Gy/day radiations for 5 consecutive days at a fixed dose 
rate of 0.699 Gy/min in Bhabatron II Cobalt-60 tele therapy 
unit in a field size of 2x2 cm2. A 5 mm lead metal shielding was 
done to cover all the other body parts of the mice except the 
right leg region to avoid exposure to other body parts.  
2.6 Blood and Bone marrow cells collection
For blood haematology and γH2AX experiment, mice 
from all the treatment groups were euthanised at 1 h post 
irradiation time point using cervical dislocation. Approximately 
1 ml Blood was collected from the heart by cardiac puncture 
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in EDTA tubes to avoid clotting. Total bone marrow cells 
were flushed out in PBS from both legs of the euthanised 
mice.  Similarly, for chromosomal aberration study mice 
were euthanised at 24 h using cervical dislocation, However, 
2 h prior to sacrifice 5 mg/kg body weight of colchicine was 
injected intraperitoneally for the arrest of the chromosome at 
metaphase. Total bone marrow cells were flushed out in 0.075 
M potassium chloride solution for analysis. 
2.7 Blood Haematology
20 μl of collected blood from each experimental animal 
was analysed by Nihon Kohden fully automatic haematology 
analyser.
2.8	 Flow	 Cytometric	Measurement	 of	 γH2AX
The γH2AX measurement was done as per the protocol 
mentioned in Yashavarddhan12, et al. The RBCs from isolated 
blood and total bone marrow cells were removed by RBC 
lysis buffer. RBC free cells were washed twice with PBS 
(centrifugation at 1200 rpm for 10 min) and fixed in 100 μl of 
3 per cent paraformaldehyde for 30 min on ice. The fixed cells 
were washed twice with 1 ml of PBS followed by washing 
with 1 ml of 50 mM ammonium chloride. After washing twice 
with PBS, the cells were permeabilised in 200 µl of 0.1 per 
cent Triton X-100 in PBS for 20 min at 4 °C. The blocking 
step was performed in 10 per cent BSA in PBS for 100 min at 
room temperature, followed by an overnight incubation with 
anti-phospho-histone γH2AX Ser-139 monoclonal antibody 
(1:50). The cells were then washed with PBS and incubated 
with polyclonal goat anti-mouse FITC-conjugated secondary 
antibodies (1:400) at 4 °C. The fluorescence intensity of γH2AX 
in 10,000 cells/sample was analysed using a BD flow cytometer.
2.9 chromosome aberration assay
Bone marrow cells were incubated at 37 °C for 25 min. 
The samples were then centrifuged at 400 g for 10 min. Cells 
were fixed by adding 1 ml of a fixative solution while vortexing 
at a moderate speed. The fixed cells were washed twice with 
the fixative solution. The supernatant was discarded and the 
pelleted cells were resuspended in 200 µl of fixative solution. 
Three drops of cell suspension were dropped from a distance 
of about 1 meter on a chilled glass slide at an angle of 45°. 
Slides were then air-dried and stained with 5 per cent Giemsa 
on the following day31-33. A total of 50 well spread plates were 
scored from each animal.  The total number of aberrant cells 
and different aberrations like dicentrics, rings, fragments, gaps, 
terminal deletion, centromeric attenuation, double minute 
(DM), end to end association and robertsonian translocations as 
well as severely damaged cells were scored from each group.
2.10  Statistical analysis
The data are presented as the mean ± SD of 6 variants 
from each group. Comparisons were made between the groups. 
The data was analysed using one-way analysis of variance, and 
multiple comparisons among different groups were performed 
by applying the Bonferroni t-test. A probability of <5% was 
considered significant.
3.  reSultS
3.1 Blood Haematology
Blood from euthanised mice of different treatment groups 
was analysed for whole blood counts  (WBC), lymphocytes 
and granulocytes percentage at 1 h time point (Fig. 1). In 
the untreated samples, the WBC count was 9.2±0.5 million 
cells/ml with 70.2±1.2 % of lymphocytes and 29.8±1.2% 
granulocytes populations. Animals irradiated with each fraction 
had significant (p<0.001) fall in total WBC counts. However, 
1st fraction of dose showed comparable (p>0.05) counts with 
control. The WBC counts in 1st to 5th fraction were found to be 
8.5±0.5, 4.7±0.4, 3.5±0.2, 2.4±0.3 and 2.3±0.3 million cells/ml 
respectively. In the case of differential counts, the lymphocytes 
vs granulocytes in 1st to 5th fractions were 66.2±2.8 vs 33.8±2.8, 
59.2±2.1 vs 40.8±2.1, 51.8±1.7 vs 48.2±1.7, 43.0±1.7 vs 
57.0±1.7 and 43.0±2.3 vs 57.0±2.3 respectively. The reduced 
Figure 1. Graph represents WBc and differential cell count of different treatment groups mice: (a) WBc counts at 1 h time point 
after giving different fractions of radiation, (b) Percentage of lymphocytes of different treatment groups, (c) Percentage of 
granulocytes of different treatment groups. the bars represent the mean ± SD of 6 animals. a value of p<0.05 is considered 
statistically	significant.	*=	p<0.05,	**=	p<0.01,	***=	p<0.001,	ns=	not	significant	(p>0.05).
(a) (b) (c)
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lymphocyte count corroborated with increased granulocyte 
was found from 2nd fraction of irradiation up to 5th fraction. 1st 
fraction had non-significant (p>0.05) changes when compared 
with the controls. The dose-dependent changes were observed 
in blood haematology parameters between different fractions 
of irradiated groups. A linear fall was observed up to the 4th 
fraction. However, 4th and 5th fraction doses showed comparable 
(p>0.05) cell counts (Fig. 1). 
3.2	 Assessment	 of	 γH2AX	 using	 Flow-cytometry
Flow cytometry is a rapid and quantitative method to 
measure the fluorescence intensity of a particle. For quantitative 
measurement of H2AX phosphorylation, this technique was 
used. Isolated blood and bone marrow cells were stained with 
anti-γH2AX ser-139 antibody and measured after the clinically 
relevant dose of irradiation ranging from 0-10 Gy ( 2 Gy per 
day for five consecutive days) using flow cytometry (Fig. 2). 
In untreated (0 Gy) samples 117±23 Mean fluorescence 
intensity (MFI) in blood and 114±14 MFI in bone marrow cells 
were measured with 5±2 and 9±1 percentage of the positive 
population in blood and bone marrow cells respectively. 
After exposure to 1st fraction (2 Gy), both γH2AX positive 
cells and MFI increased significantly (p<0.001) up to the 4th 
fraction (8 Gy). Although a significant increase in both MFI 
and percent positive cells were observed after 5th fraction 
(10 Gy) when compared with the non-irradiated group, there 
were no significant (p>0.05) differences between 4th fraction 
and 5th fraction. In 1st fraction, 1048±120 MFI in blood and 
1859±88 MFI in bone marrow cells with 21±3 and 32±2 
percentages of positive cells were observed respectively. In the 
case of 2nd fraction (4 Gy) 1659±85 MFI in blood and 2438±44 
MFI in bone marrow cells with 35±3 and 47±2 percentages 
of positive cells were observed respectively. Similarly, percent 
positive cells in 3rd fraction (6 Gy) and 4th fraction were 46±3 
and 60±4 in blood and 60±2 and 71±2 in bone marrow cells 
respectively. In corroboration with γH2AX positive cells, MFI 
of 4th fraction was higher than 3rd fraction (3rd vs 4th fraction: 
2673±75 vs 3083±72 in blood and 2755±43 vs 3406 ± 44 in 
bone marrow cells). 4th and 5th fractionated dose did not differ 
significantly for both MFI and percentage of γH2AX positive 
cells. At 1 h time point after 5th fraction blood cells showed 
3096±75 MFI with 60 ± 5 of positive cells and similarly, bone 
marrow showed 3424±50 MFI with 71±2 % of positive cells 
were observed (Fig. 2).
3.3 cytogenetic aberration
The frequency of aberrations in control animals is markedly 
low or even absent for some types of aberrations (Fig. 3). The 
total number of aberrations in different fractions of irradiated 
groups was significantly increased (p<0.001) when compared 
with the untreated (42.5±5.0, 63.3±4.2, 82.3±5.6, 94.5±5.2 
and 98.4±5.4 numbers of aberration from 1st to 5th fraction 
respectively). However, it was found similar for 4th 
and 5th fraction of radiation. The RT, EEA, rings 
and fragments were amongst the prominent types of 
aberrations. The RT and EEA number have shown a 
non-linear increase from 1st to 5th fractions, however, 
the frequency of RT and EEA enhanced when 
compared with control in case of all the fractions (RT 
vs EEA were 0.4±0.2 vs 1.0±0.5 in control, 3.2±0.4 
vs 14.5±1.2 in 1st, 37.7±0.6 vs 10.0±0.9 2nd, 30.2±1.2 
vs 20.8±1.0 in 3rd, 41.8±1.2 vs 39.7±0.9 in 4th and 
17.3±0.8 vs 52.3±1.1 in 5th fractions). The number 
of fragments first increased in 1st to 3rd fraction but 
later on reduced and reached the untreated values 
(Fig. 3). The frequency of rings was also enhanced in 
different fractions of radiation exposure compared to 
untreated (Fig. 3), whereas the aberrations like gaps, 
deletion and DM did not show any significant trend 
although they were observed in exposed animals 
only at various fractions of exposure (Fig. 3).
4.   DIScuSSIoN
Use of radiation for the treatment of cancer is a 
well approved, non-surgical method34. Radiotherapy 
is a commonly used practice where multiple fractions 
of a clinical dose are delivered over a period to kill 
cancer cells2,8. The success lies with the maximum 
effect of radiation on the cancer cells along with 
minimal damage to surrounding normal cells6,7. There 
are various factors governing the radio-sensitivity of 
a cell. The difference in radiation response of tumour 
and normal cells provides an opportunity to use 
interventional approaches in clinics. 
Figure	2.	 Measurement	of	γH2AX	in	mice	blood	and	bone	marrow	cells	of	
different treatment group at 1 h time point using Flow cytometry: 
(A)	and	(B)	represents	the	MFI	and	percentage	of	γH2AX	positive	
cells in the blood, (c) and (D) represents the mFI and percentage 
of	 γH2AX	positive	 cells	 in	bone	marrow.	The	bars	 represent	 the	
mean ± SD of 6 animals. a value of p<0.05 is considered statistically 
significant.	*=p<0.05,	**=p<0.01,	***=p<0.001,	ns=not	significant	
(p>0.05).
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Numerous reports clearly indicate killing of the tumour 
cells during split dose regimen of radiotherapy30. The 
fractionation of radiation leads to an effective killing of the 
tumour with each consecutive dose which is shown to be more 
effective than earlier delivered dose7,30. The response of normal 
cells to the repeated dose of radiation is not available. The 
present investigation aims to evaluate DNA damage induction 
in normal cells exposed to the repeated dose of radiation. The 
localised 2 Gy radiation was delivered to the right leg of mice 
repeatedly for 5 days. Directly exposed bone marrow and 
indirectly exposed blood cells of mice were measured for DNA 
damage. The latest biomarker γH2AX has been used for the 
quantification of DNA damage. Similarly, a well established 
conventional cytogenetic assay was used to confirm the DNA 
damage. The overall haematology system of the animal was 
observed through blood haematology. 
The present study showed that significant level of γH2AX 
was found in blood and bone marrow cells of mice after 1st 
dose of radiation delivered to right leg. The linear increase in 
γH2AX formation was observed up to 4th split dose of radiation 
in comparison to the untreated controls. The 5th fractionated 
dose to animals leads to similar γH2AX level as observed in 
4th fractions. In our chromosomal aberrations study, we have 
observed different types of alterations such as fragments, rings, 
gaps, robertsonian translocations (RT), end to end associations 
(EEA), deletion, and double minute (DM). The frequency 
of chromosomal aberrations was increased with increasing 
fractions and duration of radiation. Aberrations like 
fragments and rings were almost constant in the fractions 
that followed the 1st split dose but the frequency of RT and 
eeA increased significantly during successive doses.  This 
finding is in resonance with earlier reports conveying RT 
and EEA have been measured at small doses of radiation31-33. 
After giving 5th fractioned dose the damage level was found 
comparable to 4th dose. The stabilization of chromosomal 
damage from 4th to 5th split dose corroborates with the 
finding of γH2AX study.  Blood haematology indicated fall 
in WBC count in a dose-dependent manner. However, the 
total counts in 4th split treated groups were almost equal 
to the 5th fraction. Decrease in lymphocytes with increased 
granulocytes was observed in all irradiated groups. The 
comparable WBC count of the 4th and 5th split dose treated 
groups clearly supports damage stabilization, as observed 
in γH2AX and chromosomal aberration studies. 
The above study explicitly shows adaptation of 
normal cells to the radiation stress after repeated exposure. 
The differential response of normal and tumour cells 
exposed to the repeated exposure may be based on repair 
mechanisms and type of cells35. In the case of fractionated 
radiation doses, the damage to DNA is not as severe due to 
the low dose and repair of damaged DNA occurs between 
exposures12. In brief, after giving 1st split dose of radiation 
the body repair mechanism gets activated and damage 
would be repaired if it was not too extensive. However, 
after 2nd and subsequent doses, the pre-activated repair 
mechanism can easily counter the damage. In other words, 
the fractionated low-dose exposure induced a balance 
between the damage induction and repair which lead 
to stabilization of DNA damage36. In the present study, 
similar balance in damage induction and repair was observed 
in non-dividing blood and proliferative bone marrow cells. The 
possible reason is based on the fact that the bone marrow cells 
divide and form blood cells based on the system requirement 
against any stress. The balance between damage and repair 
against repeated exposure in normal cells might involve the 
regulated response of repair mechanism, although, this type of 
control is not available in tumour cells where division occurs 
in uncontrolled fashion37,38.
Besides the above findings, we also found damage in the 
blood cells on 1 h after 1st split dose of radiation. This could be 
due to the direct exposure of blood which was passing through 
the exposure area at the time of radiation and possibly due to 
bystander effect. Similar observations have been previously 
proved under in vitro and ex vivo conditions39-42.  
Considering all the results, our study indicates that the 
normal cells get adapted to damage due to multiple low dose 
exposure. 
5. coNcluSIoNS 
The present work has greater application in studying the 
response of normal cells against repeated radiation exposure. 
Since in radiotherapy, both normal and tumour cells are present 
the actual outcome of the current study may differ due to the 
interaction among cells. Further studies are needed in this 
direction.
Figure 3. chromosomal aberration study in mouse bone marrow after 
different fractions of radiation: (a) representative image of 
the different type of aberration found in mouse bone marrow 
and (b) Different type of aberration and the total number of 
aberration of different treatment group. the bars represent 
the mean ± SD of 6 animals.
(a)
(b)
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